Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: Evidence from urinary steroid hormone analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 3, 2012, Pages

  Kamrath, Clemens ^a   Hochberg, Ze'ev ^c   Hartmann, Michaela F ^a   Remer, Thomas ^b   Wudy, Stefan A ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b RESEARCH INSTITUTE OF CHILD NUTRITION   (Germany)

^c MEYER CHILDREN S HOSPITAL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

5ALPHA PREGNANE 3ALPHA,17ALPHA DIOL 20 ONE; ANDROSTERONE; ETIOCHOLANOLONE; STEROID 21 MONOOXYGENASE; STEROID HORMONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ALTERNATIVE BACKDOOR PATHWAY; ANDROGEN SYNTHESIS; ARTICLE; CHILD; COHORT ANALYSIS; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; CONTROLLED STUDY; FEMALE; HORMONE DETERMINATION; HORMONE METABOLISM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; STEROID 21 MONOOXYGENASE DEFICIENCY; STEROID URINE LEVEL; URINALYSIS;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; ANDROSTENEDIONE; ANDROSTERONE; CHILD; CHILD, PRESCHOOL; DIHYDROTESTOSTERONE; ETIOCHOLANOLONE; FEMALE; GONADAL STEROID HORMONES; HUMANS; INFANT; INFANT, NEWBORN; MALE; STEROID 17-ALPHA-HYDROXYLASE;

EID: 84858064955     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1997     Document Type: Article

References (28)

1. Auchus RJ, Lee TC, Miller WL 1998 Cytochrome b5 augments the 17,20 lyase activity of human P450c17 without direct electron transfer. J Biol Chem 273:3158-3165 (Pubitemid 28109723)
2. Flü ck CE, Miller WL, Auchus RJ 2003 The 17, 20-lyase activity of cytochrome P450c17 from human fetal testis favors the Δ5 steroidogenic pathway. J Clin Endocrinol Metab 88:3762-3766
3. Wilson JD 2001 The role of 5α-reduction in steroid hormone physiology. Reprod Fertil Dev 13:673-678 (Pubitemid 34240215)
4. Auchus RJ 2004 The backdoor pathway to dihydrotestosterone. Trends Endocrinol Metab 15:432-438 (Pubitemid 39440726)
5. Wilson JD, Auchus RJ, Leihy MW, Guryev OL, Estabrook RW, Osborn SM, Shaw G, Renfree MB 2003 5α-Androstane-3α,17β-diol is formed in tammar wallaby pouch young testes by a pathway involving 5α-pregnane- 3α,17α-diol-20-one as a key intermediate. Endocrinology 144:575-580 (Pubitemid 36205230)
6. Gupta MK, Guryev OL, Auchus RJ 2003 5α-Reduced C21 steroids are substrates for human cytochrome P450c17. Arch Biochem Biophys 418:151-160 (Pubitemid 37159381)
7. Mahendroo M, Wilson JD, Richardson JA, Auchus RJ 2004 Steroid 5α-reductase 1 promotes 5α-androstane-3α,17β-diol synthesis in immature mouse testes by two pathways. Mol Cell Endocrinol 222: 113-120 (Pubitemid 38900820)
8. Frederiksen DW, Wilson JD 1971 Partial characterization of the nuclear reduced nicotinamide adenine dinucleotide phosphate: Δ 4-3-ketosteroid 5α-oxidoreductase of rat prostate. J Biol Chem 246:2584-2593
9. White PC, Speiser PW 2000 Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 21:245-291 (Pubitemid 32275589)
10. Arlt W, Walker EA, Draper N, Ivison HE, Ride JP, Hammer F, Chalder SM, Borucka-Mankiewicz M, Hauffa BP, Malunowicz EM, Stewart PM, Shackleton CH 2004 Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study. Lancet 363:2128-2135 (Pubitemid 38844154)
11. Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, Meyer-Bahlburg HF, Miller WL, Montori VM, Oberfield SE, Ritzen M, White PC 2010 Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 95:4133-4160
12. Wudy SA, Hartmann M, Homoki J 2000 Hormonal diagnosis of 21-hydroxylase deficiency in plasma and urine of neonates using bench top gas chromatography-mass spectrometry. J Endocrinol 165:679-683 (Pubitemid 30407696)
13. Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH 2010 Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol 121:496-504
14. Wudy SA and Homoki J 2003 Profiling steroids by gas chromatography- mass spectrometry: clinical applications. In: Ranke MB, ed. Diagnostics of endocrine function in children and adolescents. Basel, Switzerland: Karger; 427-449
15. Remer T, Boye KR, Hartmann MF, Wudy SA 2005 Urinary markers of adrenarche: reference values in healthy subjects, aged 3-18 years. J Clin Endocrinol Metab 90:2015-2021 (Pubitemid 40586233)
16. Shackleton CHL 1993 Mass spectrometry in the diagnosis of steroid related disorders and in hypertension research. J Steroid Biochem Molec Biol 45:127-140 (Pubitemid 23123154)
17. Remer T, Boye KR, Hartmann M, Neu CM, Schoenau E, Manz F, Wudy SA 2003 Adrenarche and bone modeling and remodeling at the proximal radius: weak androgens make stronger cortical bone in healthy children. J Bone Miner Res 18:1539-1546 (Pubitemid 41070809)
18. Schmidt M, Kreutz M, Löffler G, Schölmerich J, Straub RH 2000 Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol 164:161-169 (Pubitemid 30114663)
19. Shackleton CH, Neres MS, Hughes BA, Stewart PM, Kater CE 2008 17-Hydroxylase/C17,20-lyase (CYP17) is not the enzyme responsible for side-chain cleavage of cortisol and its metabolites. Steroids 73:652-656
20. Homma K, Hasegawa T, Nagai T, Adachi M, Horikawa R, Fujiwara I, Tajima T, Takeda R, Fukami M, Ogata T 2006 Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: implication for the backdoor pathway to dihydrotestosterone. J Clin Endocrinol Metab 91:2643-2649 (Pubitemid 44024631)
21. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW 1993 Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest 92:903-910 (Pubitemid 23262413)
22. Flück CE, Meyer-Böni M, Pandey AV, Kempná P, Miller WL, Schoenle EJ, Biason-Lauber A 2011 Why boys will be boys: two pathways of fetal testicular androgen biosynthesis are needed for male sexual differentiation. Am J Hum Genet 89:201-218
23. Penning TM, Burczynski ME, Jez JM, Hung CF, Lin HK, Ma H, Moore M, Palackal N, Ratnam K 2000 Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones. Biochem J 351:67-77
24. Dufort I, Labrie F, Luu-The V 2001 Human types 1 and 3 3α-hydroxysteroid dehydrogenases: differential lability and tissue distribution. J Clin Endocrinol Metab 86:841-846 (Pubitemid 32208285)
25. Dufort I, Rheault P, Huang XF, Soucy P, Luu-The V 1999 Characteristics of a highly labile human type 5 17β-hydroxysteroid dehydrogenase. Endocrinology 140:568-574 (Pubitemid 29058186)
26. Luu-The V, Dufort I, Pelletier G, Labrie F 2001 Type 5 17β-hydroxysteroid dehydrogenase: its role in the formation of androgens in women. Mol Cell Endocrinol 171:77-82 (Pubitemid 32098200)
27. Belyaeva OV, Chetyrkin SV, Clark AL, Kostereva NV, SantaCruz KS, Chronwall BM, Kedishvili NY 2007 Role of microsomal retinol/sterol dehydrogenase-like short-chain dehydrogenases/reductases in the oxidation and epimerization of 3α-hydroxysteroids in human tissues. Endocrinology 148:2148-2156 (Pubitemid 46997028)
28. Pandey AV, Miller WL 2005 Regulation of 17,20 lyase activity by cytochrome b5 and by serine phosphorylation of P450c17. J Biol Chem 280:13265-13271 (Pubitemid 40517210)